Tactic Pharma LLC - 24 Sep 2025 SCHEDULE 13D/A Report for Monopar Therapeutics Common Stock, $0.001 par value (MNPR)

Filing Manager
Tactic Pharma LLC
Reporting Manager
Robinson Chandler
Security
Monopar Therapeutics Common Stock, $0.001 par value
Symbol
MNPR
Shares outstanding
6,749,320 shares
Disclosed Ownership
506,199 shares
Ownership
7.5%
Form type
SCHEDULE 13D/A
Filing time
24 Sep 2025, 20:59:11 UTC
Date of event
24 Sep 2025
Next filing
30 Jan 2026
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Tactic Pharma LLC 4.1% 272,026 272,026 0 /s/ Chandler Robinson Chandler Robinson 0001727357
Mazar Andrew Paul 4.1% 272,026 1 272,026 /s/ Andrew Mazar Andrew Mazar 0001727393
Robinson Chandler 7.5% 506,199 234,173 272,026 /s/ Chandler Robinson Chandler Robinson 0001727334
O'Halloran Thomas V. 4.1% 272,026 2,801 272,026 /s/ Thomas O'Halloran Thomas O'Halloran 0001727481
Brown Michael J 5.1% 338,067 66,051 272,026 /s/ Michael Brown Michael Brown 0001035909